from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2551c/-

LFCtreatmentdescriptionclass of inhibitor

0.112

Amikacinug/mL Amikacintranslation

-0.863

Cap5-10ug/mL Capreomycintranslation

-1.121

Rox10-50 ug/mL Roxithromycintranslation

-0.637

SM2-5 ug/mL Streptomycintranslation

-0.807

Tet5-10 ug/mL Tetracyclinetranslation

0.158

Rif0.2-5ug/mL Rifampicintranscription

0.865

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.061

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.785

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.181

CPZ10-50 ug/mL Chlorpromazinerespiration

0.881

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.182

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.310

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.468

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.491

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.186

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.347

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.394

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.679

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.105

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.796

KCN5-20 ug/mL Potassium cyaniderespiration

-0.204

NaN30.2-2 mM Sodium aziderespiration

-0.534

Nigericin50 uM Nigericinrespiration

0.874

TRC10-150 ug/mL Triclosanrespiration

0.815

TRZ10-25 ug/mL Thioridazinerespiration

0.364

Valinomycin0.5-10 uM Valinomycinrespiration

-1.696

ZnSO42 mM ZnSO4respiration

0.129

menadione6-10 ug/mL Menadionerespiration

0.726

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.726

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.326

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.831

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.584

NRP_1Non-replicating persistence stage 1dosRassociated

-0.448

Amp0.2mg/mL AmpicillincellWall

-0.069

Cephalexin20-100 ug/mL CephalexincellWall

-0.038

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.024

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.267

EMB10-20 ug/mL EthambutolcellWall

-0.520

Eta12-40 ug/mL EthionamidecellWall

-0.785

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.070

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.083

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.531

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.859

BZA0.12 mg/mL BenzamidearomaticAmides

-0.646

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.635

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.122

H2O24 mM hydrogen peroxideDNAdamaging

0.419

Levo10 ug/mL LevofloxacinDNAdamaging

-0.951

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.182

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.402

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.450

UVUV-irradiationDNAdamaging

2.172

ARP41-4 ug/mL Antitubercular compound ARP4?

0.675

Antimycin12.5-50 ug/mL Antimycin A?

0.086

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.583

PA_110-50 ug/mL Antitubercular compound PA-1?

0.576

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.577

PA8240.2-2 ug/mL PA-824?

1.150

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.269

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.055

Verapamil50 uM Verapamil?

-0.232

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.125

methoxatin10-20 ug/mL Methoxatin?